PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-26 Cr | ₹148 Cr | ₹-37 Cr | ₹-251 Cr | ₹94 Cr |
What is the latest Net Cash Inflow / Outflow ratio of PIRAMAL PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-26 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-251 Cr |
| Mar2021 | ₹94 Cr |
How is Net Cash Inflow / Outflow of PIRAMAL PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-26 Cr | Negative | |
| Mar2024 | ₹148 Cr | Positive | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-251 Cr | Negative | |
| Mar2021 | ₹94 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,753.4 Cr | 1.3% | -6.6% | -19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 1.3% |
-6.6% |
-19.9% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses